IL6 and myeloid sarcoma: Additionally, multiple components of the TH17 cell differentiation pathway (IL6, STAT3, IL21) are located near loci that have been identified to confer susceptibility to MS [50] and targeting components of TH17 cell differentiation and function has also been shown to confer resistance or lead to attenuated disease in EAE [61], [62].